Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global market revenue, 2014-2022 (USD Million)
2.2. Global organ preservation market: Snapshot
Chapter 3. Organ Preservation market Global and Industry Analysis
3.1. Organ preservation market: Market dynamics
3.2. Market drivers
3.2.1. Drivers of global organ preservation market: Impact analysis
3.2.2. Increasing cases of multiple organ failure in aging
3.2.3. Technological advancements
3.3. Market restraints
3.3.1. Restraints of organ preservation market: Impact analysis
3.3.2. High cost of procedure
3.4. Opportunities
3.4.1. Research development for more innovative preservation methods
3.5. Porters five forces analysis
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis by technique
3.6.2. Market attractiveness analysis by preservation solution
3.6.3. Market attractiveness analysis by organ type
3.6.4. Market attractiveness analysis by region
Chapter 4. Global Organ Preservation market - Competitive Landscape
4.1. Company market share, 2015
4.1.1. Global organ preservation market: company market share, 2015
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Type Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Type and Regional Expansion
Chapter 5. Global Organ Preservation market Technique Analysis
5.1. Global organ preservation market: Technique overview
5.1.1. Global organ preservation market revenue share, by technique, 2014-2022
5.2. Static Cold Storage
5.2.1. Global static cold storage market, 2014-2022 (USD Million)
5.3. Hypothermic Perfusion Preservation
5.3.1. Global hypothermic perfusion preservation market , 2014-2022 (USD Million)
5.4. Others
5.4.1. Global other types of organ preservation techniques market , 2014-2022 (USD Million)
Chapter 6. Global Organ Preservation market Preservation Solution Analysis
6.1. Global organ preservation market: Preservation solution overview
6.1.1. Global organ preservation market revenue share, by preservation solution, 2014-2022
6.2. Viaspan
6.2.1. Global organ viaspan solution market revenue, 2014-2022 (USD Million)
6.3. Custodiol HTK
6.3.1. Global Custodiol HTK solution market revenue, 2014-2022 (USD Million)
6.4. Renograf
6.4.1. Global Renograf solution market revenue, 2014-2022 (USD Million)
6.5. Perfadex
6.5.1. Global Perfadex solution market revenue, 2014-2022 (USD Million)
6.6. Human bioSystem (HBS) Solution
6.6.1. Global Human bioSystem (HBS) Solution solution market revenue, 2014-2022 (USD Million)
6.7. Lifor
6.7.1. Global Lifor solution market revenue, 2014-2022 (USD Million)
6.8. Others
6.8.1. Global other organ preservative solutions market revenue, 2014-2022 (USD Million)
Chapter 7. Global Organ Preservation market Organ Type Analysis
7.1. Global organ preservation market: Organ type overview
7.1.1. Global organ preservation market revenue share, by organ type, 2014-2022
7.2. Kidneys
7.2.1. Global organ preservation market for kidneys, 2014-2022 (USD Million)
7.3. Lung
7.3.1. Global organ preservation market for lungs, 2014-2022 (USD Million)
7.4. Liver
7.4.1. Global organ preservation market for liver, 2014-2022 (USD Million)
7.5. Heart
7.5.1. Global organ preservation market for Heart, 2014-2022 (USD Million)
7.6. Others
7.6.1. Global organ preservation market for other organs , 2014-2022 (USD Million)
Chapter 8. Global Organ Preservation market Regional Analysis
8.1. Global organ peservatives market: Regional overview
8.1.1. Global organ preservation market revenue share by region, 2014-2022
8.2. North America
8.2.1. North America organ preservation market revenue, by technique, 2014-2022 (USD Million)
8.2.2. North America organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.2.3. North America organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.2.4. U.S.
8.2.4.1. U.S. organ preservation market revenue, by technique, 2014 2022(USD Million)
8.2.4.2. U.S. organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.2.4.3. U.S. organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.3. Europe
8.3.1. Europe organ preservation market revenue, by technique, 2014-2022 (USD Million)
8.3.2. Europe organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.3.3. Europe organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.3.4. U.K.
8.3.4.1. U.K. organ preservation market revenue, by technique, 2014 2022(USD Million)
8.3.4.2. U.K. organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.3.4.3. U.K. organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.3.5. France
8.3.5.1. France organ preservation market revenue, by technique, 2014 2022(USD Million)
8.3.5.2. France organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.3.5.3. France organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.3.6. Germany
8.3.6.1. Germany organ preservation market revenue, by technique, 2014 2022(USD Million)
8.3.6.2. Germany organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.3.6.3. Germany organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific organ preservation market revenue, by technique, 2014-2022 (USD Million)
8.4.2. Asia Pacific organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.4.3. Asia Pacific organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.4.4. China
8.4.4.1. China organ preservation market revenue, by technique, 2014 2022(USD Million)
8.4.4.2. China organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.4.4.3. China organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.4.5. India
8.4.5.1. India organ preservation market revenue, by technique, 2014 2022(USD Million)
8.4.5.2. India organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.4.5.3. India organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.4.6. Japan
8.4.6.1. Japan organ preservation market revenue, by technique, 2014 2022(USD Million)
8.4.6.2. Japan organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.4.6.3. Japan organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.5. Latin America
8.5.1. Latin America organ preservation market revenue, by technique, 2014-2022 (USD Million)
8.5.2. Latin America organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.5.3. Latin America organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.5.4. Brazil
8.5.4.1. Brazil organ preservation market revenue, by technique, 2014 2022(USD Million)
8.5.4.2. Brazil organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.5.4.3. Brazil organ preservation market revenue, by organ type, 2014-2022 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa organ preservation market revenue, by technique, 2014-2022 (USD Million)
8.6.2. Middle East and Africa organ preservation market revenue, by preservation solution, 2014-2022 (USD Million)
8.6.3. Middle East and Africa organ preservation market revenue, by organ type, 2014-2022 (USD Million)
Chapter 9. Company Profile
9.1. BioLife Solutions, Inc.
9.1.1. Financials
9.1.2. Technique portfolio
9.1.3. Business strategy
9.1.4. Recent developments
9.2. BioTime, Inc.
9.2.1. Overview
9.2.2. Financials
9.2.3. Technique portfolio
9.2.4. Business strategy
9.2.5. Recent developments
9.3. Claris Lifesciences Limited
9.3.1. Overview
9.3.2. Financials
9.3.3. Technique portfolio
9.3.4. Business strategy
9.3.5. Recent developments
9.4. CryoLife, Inc.
9.4.1. Overview
9.4.2. Financials
9.4.3. Technique portfolio
9.4.4. Business strategy
9.4.5. Recent developments
9.5. Bristol-Myers Squibb
9.5.1. Overview
9.5.2. Financials
9.5.3. Technique portfolio
9.5.4. Business strategy
9.5.5. Recent developments
9.6. Lifeline Scientific
9.6.1. Overview
9.6.2. Financials
9.6.3. Technique portfolio
9.6.4. Business strategy
9.6.5. Recent developments
9.7. Dr. Franz Khler Chemie GmbH
9.7.1. Overview
9.7.2. Financials
9.7.3. Technique portfolio
9.7.4. Business strategy
9.7.5. Recent developments
9.8. Teva Pharmaceutical Industries Ltd
9.8.1. Overview
9.8.2. Financials
9.8.3. Technique portfolio
9.8.4. Business strategy
9.8.5. Recent developments
9.9. Preservation Solutions, Inc.
9.9.1. Overview
9.9.2. Financials
9.9.3. Technique portfolio
9.9.4. Business strategy
9.9.5. Recent developments
9.10. ToleroTech, Inc.
9.10.1. Overview
9.10.2. Financials
9.10.3. Technique portfolio
9.10.4. Business strategy
9.10.5. Recent developments